MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cmi.2026.05.002

Медицинская библиотека · Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2026

Early antifungal prophylaxis fails to prevent influenza-associated pulmonary aspergillosis in the ICU: a target trial emulation.

Li Peng, Xu Shengnan, Chen Chao, Hu Xingang, Li Yajun, Wang Jinlai, Guo Leilei, Qiao Bo, Li Yuanyuan, Zhou Yansheng, Hu Xiufeng, Guo Yanyan, Hu Bin, Zheng Sangang, Liu Junping, Fan Pengli, Zhang Jiangfeng, Bao Junzhe, Sun Mingjie

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

OBJECTIVES

To evaluate whether early antifungal prophylaxis reduces the incidence of influenza-associated pulmonary aspergillosis (IAPA) in critically ill adults with influenza.

METHODS

We emulated a target trial using a multicentre cohort of critically ill adults with influenza from 48 intensive care units (ICUs) (2023-2025). The intervention was antifungal prophylaxis within 24 hours of ICU admission versus no prophylaxis. We used directed acyclic graphs and inverse probability of treatment weighting to control for confounding. The primary outcome was IAPA incidence after the first 48 hours of ICU stay. Secondary outcomes included hepatotoxicity, nephrotoxicity, 14-day nondeath ICU discharge, and 28-day all-cause mortality.

RESULTS

Among 2919 eligible patients, 448 (15.3%) received early prophylaxis. The overall incidence of IAPA was 7.0%. In the crude analysis, IAPA occurred in 16 of 448 (3.6%) patients in the prophylaxis group versus 189 of 2471 (7.6%) in the no prophylaxis group, corresponding to a reduced hazard (hazard ratio [HR] 0.46, 95% CI 0.27-0.76). However, after inverse probability of treatment weighting adjustment to emulate randomization, prophylaxis showed no significant protective effect (HR 0.88, 95% CI 0.48-1.63; p 0.693). Subgroup analysis revealed significant effect modification by ICU-specific baseline IAPA incidence (p for interaction <0.001), with a protective association observed only in the highest incidence tertile (HR 0.28, 95% CI 0.08-0.91). Prophylaxis was associated with an increased risk of hepatotoxicity (adjusted OR 1.58, 95% CI 1.35-1.86; p < 0.001) but showed no significant effect on nephrotoxicity, ICU discharge, or mortality.

CONCLUSIONS

Early antifungal prophylaxis did not reduce IAPA incidence overall and was associated with increased hepatotoxicity, without improving clinical outcomes. The observed heterogeneity across ICUs suggests that a universal prophylaxis strategy is not justified.

Для цитирования: Li Peng, Xu Shengnan, Chen Chao, Hu Xingang, Li Yajun, Wang Jinlai, Guo Leilei, Qiao Bo, Li Yuanyuan, Zhou Yansheng, Hu Xiufeng, Guo Yanyan, Hu Bin, Zheng Sangang, Liu Junping, Fan Pengli, Zhang Jiangfeng, Bao Junzhe, Sun Mingjie. Early antifungal prophylaxis fails to prevent influenza-associated pulmonary aspergillosis in the ICU: a target trial emulation.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2026. DOI: 10.1016/j.cmi.2026.05.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.